Information om | Engelska ordet HYDROXAMIC

Exempel på hur man kan använda HYDROXAMIC i en mening

• Phytochemical reports on genus Aphelandra are Alkaloids, Flavonoids, Isoflavones, Benzoxazinoids-cyclic hydroxamic acid and their corresponding glucosides.
• Suberoylanilide hydroxamic acid (SAHA) (a HDAC inhibitor) increases expression of aquaporin-3 in normal skin cells (keratinocytes).
• In a variation on the Nef reaction, primary nitro compounds kept in an acidic solution (to minimize the nitronate tautomer) hydrolyze to a hydroxamic acid.
• After intramolecular proton exchange to 5 a sulfinic acid anion is split off and hydroxamic acid 8 results through nitroso compound 6 and intermediate 7.
• Hydroxylammonium chloride is used in organic synthesis for preparation of oximes and hydroxamic acids from carboxylic acids, N- and O- substituted hydroxylamines, and addition reactions of carbon-carbon double bond.
• He devoted his attention chiefly to organic chemistry and published papers on nitro-paraffin salts, alkyl derivatives of hydroxylamine, preparation of hydroxamic acids from hydroxylamines, electron conception of valence, and preparation of electromeres.
• Hydroxamic acids, such as salicylhydroxamic acid, and oximes are commonly utilized in metallacrown ligands.
• Because of this, aspergillic acid has been assigned the corresponding l-oxide or tautomeric pyridine hydroxamic acid structure show below.
• Pracinostat (SB939) is an orally bioavailable, small-molecule histone deacetylase (HDAC) inhibitor based on hydroxamic acid with potential anti-tumor activity characterized by favorable physicochemical, pharmaceutical, and pharmacokinetic properties.
• The five classes of HDACi consist of (I) hydroxamic acids, (II) short-chain fatty acids, (III) benzamides, (IV) cyclic tetrapeptides, and (V) sirtuin inhibitors.
• Butler, "Suberoylanilide hydroxamic acid (vorinostat) represses androgen receptor expression and acts synergistically with an androgen receptor antagonist to inhibit prostate cancer cell proliferation," Molecular Cancer Therapeutics 6, no.

Förberedelsen av sidan tog: 335,46 ms.